183 related articles for article (PubMed ID: 34396437)
1. Plasma‑derived exosomal pyruvate kinase isoenzyme type M2 accelerates the proliferation and motility of oesophageal squamous cell carcinoma cells.
Yang L; Zheng S; Liu Q; Liu T; Zhang Q; Han X; Tuerxun A; Lu X
Oncol Rep; 2021 Oct; 46(4):. PubMed ID: 34396437
[TBL] [Abstract][Full Text] [Related]
2. M2 isoform of pyruvate kinase (PKM2) is upregulated in Kazakh's ESCC and promotes proliferation and migration of ESCC cells.
Liu Q; Liang M; Liu T; Vuitton L; Zheng S; Gao X; Lu M; Li X; Sheyhidin I; Lu X
Tumour Biol; 2016 Feb; 37(2):2665-72. PubMed ID: 26404132
[TBL] [Abstract][Full Text] [Related]
3. SUMOylation of HSP27 regulates PKM2 to promote esophageal squamous cell carcinoma progression.
Zhang X; Liu T; Zheng S; Liu Q; Shen T; Han X; Zhang Q; Yang L; Lu X
Oncol Rep; 2020 Oct; 44(4):1355-1364. PubMed ID: 32945483
[TBL] [Abstract][Full Text] [Related]
4. The mTOR Pathway Regulates PKM2 to Affect Glycolysis in Esophageal Squamous Cell Carcinoma.
Xiaoyu H; Yiru Y; Shuisheng S; Keyan C; Zixing Y; Shanglin C; Yuan W; Dongming C; Wangliang Z; Xudong B; Jie M
Technol Cancer Res Treat; 2018 Jan; 17():1533033818780063. PubMed ID: 29916308
[TBL] [Abstract][Full Text] [Related]
5. Pyruvate kinase M2 is highly correlated with the differentiation and the prognosis of esophageal squamous cell cancer.
Zhan C; Shi Y; Lu C; Wang Q
Dis Esophagus; 2013; 26(7):746-53. PubMed ID: 23317289
[TBL] [Abstract][Full Text] [Related]
6. CAF-derived exosomes deliver LINC01410 to promote epithelial-mesenchymal transition of esophageal squamous cell carcinoma.
Shi Z; Jiang T; Cao B; Sun X; Liu J
Exp Cell Res; 2022 Mar; 412(2):113033. PubMed ID: 35041823
[TBL] [Abstract][Full Text] [Related]
7. Exosomal lncRNA ZFAS1 regulates esophageal squamous cell carcinoma cell proliferation, invasion, migration and apoptosis via microRNA-124/STAT3 axis.
Li Z; Qin X; Bian W; Li Y; Shan B; Yao Z; Li S
J Exp Clin Cancer Res; 2019 Nov; 38(1):477. PubMed ID: 31775815
[TBL] [Abstract][Full Text] [Related]
8. Cisplatin-resistant NSCLC cells induced by hypoxia transmit resistance to sensitive cells through exosomal PKM2.
Wang D; Zhao C; Xu F; Zhang A; Jin M; Zhang K; Liu L; Hua Q; Zhao J; Liu J; Yang H; Huang G
Theranostics; 2021; 11(6):2860-2875. PubMed ID: 33456577
[TBL] [Abstract][Full Text] [Related]
9. Dihydroartemisinin mediating PKM2-caspase-8/3-GSDME axis for pyroptosis in esophageal squamous cell carcinoma.
Jiang M; Wu Y; Qi L; Li L; Song D; Gan J; Li Y; Ling X; Song C
Chem Biol Interact; 2021 Dec; 350():109704. PubMed ID: 34655567
[TBL] [Abstract][Full Text] [Related]
10. Effect of modified Jianpi Yangzheng on regulating content of PKM2 in gastric cancer cells-derived exosomes.
Wu J; Yuan M; Shen J; Chen Y; Zhang R; Chen X; Wang H; Yin Z; Zhang X; Liu S; Sun Q
Phytomedicine; 2022 Aug; 103():154229. PubMed ID: 35691076
[TBL] [Abstract][Full Text] [Related]
11. Pyruvate Kinase M2 Modulates Esophageal Squamous Cell Carcinoma Chemotherapy Response by Regulating the Pentose Phosphate Pathway.
Fukuda S; Miyata H; Miyazaki Y; Makino T; Takahashi T; Kurokawa Y; Yamasaki M; Nakajima K; Takiguchi S; Mori M; Doki Y
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1461-8. PubMed ID: 25808097
[TBL] [Abstract][Full Text] [Related]
12. Nuclear PKM2 expression predicts poor prognosis in patients with esophageal squamous cell carcinoma.
Zhang X; He C; He C; Chen B; Liu Y; Kong M; Wang C; Lin L; Dong Y; Sheng H
Pathol Res Pract; 2013 Aug; 209(8):510-5. PubMed ID: 23880164
[TBL] [Abstract][Full Text] [Related]
13. Proteomic profiling of plasma exosomes reveals CD82 involvement in the development of esophageal squamous cell carcinoma.
Yang L; Salai A; Sun X; Liu Q; Liu T; Zhang Q; Tuerxun A; Tan Y; Zheng S; Lu X
J Proteomics; 2022 Aug; 265():104662. PubMed ID: 35728771
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of pyruvate kinase M2 isoform inhibits cell motility in hepatocellular carcinoma cells.
Chen YL; Song JJ; Chen XC; Xu W; Zhi Q; Liu YP; Xu HZ; Pan JS; Ren JL; Guleng B
World J Gastroenterol; 2015 Aug; 21(30):9093-102. PubMed ID: 26290635
[TBL] [Abstract][Full Text] [Related]
15. Tumor-derived exosomal miR-103a-2-5p facilitates esophageal squamous cell carcinoma cell proliferation and migration.
Gao DC; Hou B; Zhou D; Liu QX; Zhang K; Lu X; Zhang J; Zheng H; Dai JG
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(11):6097-6110. PubMed ID: 32572925
[TBL] [Abstract][Full Text] [Related]
16. PKM2-regulated STAT3 promotes esophageal squamous cell carcinoma progression via TGF-β1-induced EMT.
Ma R; Liu Q; Zheng S; Liu T; Tan D; Lu X
J Cell Biochem; 2019 Jul; 120(7):11539-11550. PubMed ID: 30756445
[TBL] [Abstract][Full Text] [Related]
17. RNA sequencing of exosomes revealed differentially expressed long noncoding RNAs in early-stage esophageal squamous cell carcinoma and benign esophagitis.
Tian L; Yang L; Zheng W; Hu Y; Ding P; Wang Z; Zheng D; Fu L; Chen B; Xiao T; Wang Y; Chen F; Liu J; Gao K; Shen S; Zhai R
Epigenomics; 2020 Mar; 12(6):525-541. PubMed ID: 32043367
[No Abstract] [Full Text] [Related]
18. [Corrigendum] Plasma‑derived exosomal pyruvate kinase isoenzyme type M2 accelerates the proliferation and motility of oesophageal squamous cell carcinoma cells.
Yang L; Zheng S; Liu Q; Liu T; Zhang Q; Han X; Tuerxun A; Lu X
Oncol Rep; 2022 Mar; 47(3):. PubMed ID: 34981822
[TBL] [Abstract][Full Text] [Related]
19. Serum exosomal miR-182 upregulation predicts unfavorable prognosis of esophageal squamous cell carcinoma.
Qiu ML; Li X; Lin JB; Luo RG; Liu B; Feng Z
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5412-5418. PubMed ID: 32495876
[TBL] [Abstract][Full Text] [Related]
20. Expression patterns of three regulation enzymes in glycolysis in esophageal squamous cell carcinoma: association with survival.
Li W; Xu Z; Hong J; Xu Y
Med Oncol; 2014 Sep; 31(9):118. PubMed ID: 25064730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
